Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Costs & Expenses

$39.93M

TTM · Period ending: Jun 30, 2026 · USD

LCTX Total Costs & Expenses

Latest reported$39.93Mperiod endingJun 30, 2026

Latest reported$39.93Mperiod endingJun 30, 2026

LCTX TTM Total Costs & Expenses ($1.30M → $39.93M)

TTM Total Costs & Expenses

High-resolution chart · PNG

LCTX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	4,524,787
Mar 31, 2001	4,748,263
Dec 31, 2000	5,142,772
Sep 30, 2000	5,547,158
Jun 30, 2000	6,661,469
Mar 31, 2000	6,982,609
Dec 31, 1999	6,797,211
Sep 30, 1999	6,600,000
Jun 30, 1999	5,300,000
Mar 31, 1999	4,900,000
Sep 30, 1998	5,000,000
Jun 30, 1998	4,900,000
Mar 31, 1998	5,000,000
Dec 31, 1997	4,300,000
Sep 30, 1997	3,800,000
Jun 30, 1997	3,300,000
Mar 31, 1997	0
Dec 31, 1996	-600,000
Sep 30, 1996	-1,400,000
Jun 30, 1996	-1,800,000
Mar 31, 1996	1,100,000
Dec 31, 1995	1,700,000
Sep 30, 1995	2,400,000
Jun 30, 1995	2,600,000
Mar 31, 1995	2,400,000
Dec 31, 1994	2,100,000
Sep 30, 1994	1,800,000
Jun 30, 1994	1,700,000
Mar 31, 1994	1,500,000
Dec 31, 1993	1,500,000
Sep 30, 1993	1,500,000
Jun 30, 1993	1,400,000
Mar 31, 1993	1,400,000
Dec 31, 1992	1,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.